Toxicogenomics Data on Acetaminophen Now Available by unknown
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MIT Toxicogenomics
Research Program
The Toxicogenomics Research Consortium
(TRC) was initiated by the NIEHS to inte-
grate genomics approaches into the field of
toxicology through the cooperative efforts
of research institutions from academia, gov-
ernment, and industry. At one TRC mem-
ber institution, the Massachusetts Institute
of Technology (MIT), researchers are focus-
ing their attention on the effects of simple
and complex alkylating agents, a class of
DNA-damaging environmental toxins and
toxicants that cause cell death, mutations,
birth defects, and cancer. 
The MIT Toxicogenomics Research
Program was established in September 2001
and is directed by Leona D. Samson, a pro-
fessor of toxicology and biology engineering
and director of the MIT Center for
Environmental Health Sciences. In the
short time since the first TRC grants were
awarded, the MIT program has made
numerous significant contributions to toxi-
cogenomics in scientific discovery, innova-
tion, collaboration, and education.
Alkylating Agents
Alkylating agents are highly reactive chemi-
cals that introduce alkyl groups into biologi-
cally active molecules and prevent normal
functioning. They are found in the environ-
ment and are produced within the body
during metabolism—we are, in fact, contin-
uously exposed to these agents. Most alky-
lating agents are extremely toxic; some are
used for chemotherapy. 
Samson is interested in pathways that
repair DNA alkylation damage, and any
other pathways that ameliorate or exacer-
bate their toxicity. One aspect of her
research focuses on expression of genes as a
result of exposure to alkylating agents.
Assaying gene expression using microarray
technology, her lab has identified thousands
of genes whose transcript levels are altered as
a result of exposure. 
Surprisingly, it is not only DNA repair
and cell cycle checkpoint genes that are
transcriptionally regulated upon exposure to
alkylating agents, but also genes involved in
many unexpected pathways such as protein,
RNA, and lipid metabolism. This was first
demonstrated in Saccharomyces cerevisiae,
and the Samson lab is currently exploring
whether such a broad response is evolution-
arily conserved. One current topic of inves-
tigation is the transcription response of mice
with different DNA alkylation repair capa-
bilities upon exposure to alkylating agents. 
Samson’s results challenge some of the
basic concepts of how we think about the
response of cells to DNA-damaging agents.
Further, they reveal that responses to envi-
ronmental insult are much more complex
than previously thought. It has become clear
that a global systems model is a more accu-
rate way of viewing toxicity. This insight
into the complexity of environmental expo-
sure responses led to the incorporation of
the Toxicogenomics Research Program into
the school’s Center for Environmental
Health Sciences.
Understanding Aflatoxin 
John Essigmann, a professor of chemistry,
toxicology and biological engineering,
conducts research on differential gene
expression in response to exposure to afla-
toxin, a natural DNA-damaging agent that
is widespread in the environment. Aflatoxin
is a fungal toxin produced by Aspergillus
flavus. Acute liver toxicity and liver cancer
are common features of people exposed to
aflatoxin-contaminated food, particularly
peoples in developing areas where cereal
grains are the staple food in the diet. Such
areas include sub-Saharan Africa, China,
India, and Southeast Asia, where the diet
includes lots of rice, peanuts, and maize. In
areas of the world where aflatoxin contami-
nates the food supply, there is concern that
children, especially, are compromised in
their growth and overall health.
People infected with hepatitis B have
increased sensitivity to aflatoxin carcinogen-
esis by as much as 50- to 100-fold.
Aflatoxin and hepatitis B each are major risk
factors for liver cancer (more so when com-
bined), a leading cause of cancer death in
Thailand, among other parts of the world.
Essigmann was recently awarded Thailand’s
Princess Chulabhorn Gold Medal for his
“commitment to and sustained support for
the advancement of science in developing
countries, as well as for his selfless dedica-
tion to teaching and research.” In the devel-
oping world, it is difficult to completely
eliminate aflatoxin from the diet, so
Essigmann has emphasized that it is essen-
tial to promote hepatitis vaccination for
children, as this disease is the co-etiologic
factor in the prevalence of liver cancer in
these areas.
The Essigmann lab is working to under-
stand the mechanisms of toxicity and liver
disease associated with aflatoxin exposure.
Aflatoxin reacts with guanine bases in DNA
to form adducts or lesions that can cause
errors in DNA replication; these errors pre-
sumably lead to malignancy. Aflatoxin can
form many different types of adducts, and
different organisms vary in their response to
exposure. Some species, such as rats, are
highly sensitive and susceptible, whereas
others, such as mice, are resistant.
Essigmann is particularly interested in the
reasons for the differential sensitivity of dif-
ferent species to aflatoxin, as well as the rea-
sons that hepatitis amplifies human risk of
aflatoxin carcinogenesis. 
With respect to the first question,
Essigmann has compared the sensitivity of
adult and infant mice to aflatoxin. Although
adult mice are resistant to liver cancer
induced by the fungal toxin, infant mice are
exquisitely sensitive. Four-day-old mice
exposed to aflatoxin develop cancer, but by
one week of age, they become resistant. By
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Solving a mechanistic mystery.
Researchers are studying aflatoxin, a
food contaminant that fluoresces blue
under UV light (above), to understand
genetic susceptibility. Intriguingly, afla-
toxin causes liver cancer in 4-day-old
mice (right), but week-old mice are
resistant.investigating differences in the gene expres-
sion patterns of mice exposed at different
developmental stages, Essigmann hopes to
find clues to better understand why some
people are sensitive and some are resistant,
how race and gender may affect why some
people respond to therapeutic drugs and
others do not, why infants and children are
more susceptible than adults, and why
hepatitis confers heightened sensitivity to
aflatoxin effects.
Liver on a Chip
Linda Griffith, a professor of biological
engineering and mechanical engineering
and director of the Biotechnology Process
Engineering Center at MIT, was voted one
of the annual “Brilliant 10” young scientists
by Popular Science in 2002 for her ground-
breaking research in tissue engineering and
her vision for creating the human body on
a chip. With funding from the Defense
Advanced Research Project Agency, the
central research and development agency of
the Department of Defense, Griffith
designed a prototype “liver on a chip.” The
liver is highly sensitive to all kinds of envi-
ronmental toxicants, and the objective of
the initial work was to develop a tiny,
portable biosensor that could be used in
battlefield deployment for early detection
of environmental hazards from chemical
and biological warfare. Continuing support
for further development of the liver chip
for sensing applications is provided by the
Institute for Soldier Nanotechnologies at
MIT. Among other valuable applications
for the liver on a chip is in vivo experiments
in toxicogenomics.
The liver on a chip comprises liver cells
affixed to tiny channels etched in a silicon
chip that is smaller than a quarter and
housed in a clear plastic watertight housing.
The tiny reactor holds up to 50,000 liver
cells distributed among 40 identical units
that each resemble the capillary bed, or net-
work, of a tissue. The system can readily be
scaled up to contain over a million cells in a
larger reactor with 1,000 tiny “capillary
beds.” Within the bioreactor, oxygen- and
nutrient-enriched fluid that mimics the
blood supply flows through the silicon scaf-
fold, simulating the body’s circulation sys-
tem. This miniature three-dimensional (3-
D) model of the liver maintains the
enzymes essential for metabolizing toxicants
longer and performs better than two-dimen-
sional cell culture in vitro systems. 
The 3-D microscale liver bioreactor is
an important new toxicology tool for exam-
ining in vivo gene expression in primary
liver cells in response to acute and chronic
exposure to environmental toxins and other
toxicants. With the validation of optimal
levels of gene expression of enzymes in toxin
metabolism, Griffith’s lab is starting to
employ the liver bioreactor to profile effects
of toxins on liver metabolism. Initial experi-
ments are looking at the response of rat liver
cells to aflatoxin exposure. Aflatoxin is
added to the circulating fluid, and the cells
are subsequently examined microscopically
to detect what is happening in the tissue.
Preliminary results, reported at the TRC
biannual meeting in December 2004, indi-
cate there is a dose-dependent relationship
between exposure and toxicity. 
Cell cultures, which generally are flat
and one cell thick, have a limited capacity to
reproduce in vivo cellular function. The 3-
D bioreactor provides a better simulation of
living tissue and real liver function. Liver
cells grown in the artificial structure repli-
cate and clump together to form a complex
extracellular matrix. This highly evolved
microenvironment maintains cellular signal-
ing. The liver bioreactor makes it possible to
study the complex order of tissue in a sys-
tem that can be manipulated by drugs, hor-
mones, and environmental toxins. Early
experiments are demonstrating appropriate
levels of gene expression, especially enzymes
in toxin metabolism. 
Griffith is just beginning to test the
bioreactor’s capacity to profile toxins
involved in liver metabolism. Ultimately,
she wants to conduct experiments with
human cells as an accessible way to look at
human responses to exposure.
A Group Effort
In addition to the three independent inves-
tigator-initiated projects of Samson,
Essigmann, and Griffith, the MIT scien-
tists participate as collaborators on three
projects involving investigators from TRC
cooperating research members (CRMs) as
well as a consortiumwide microarray stan-
dardization effort. 
The first project is a collaboration with
Oregon Health & Science University, the
Fred Hutchinson Cancer Research Center,
the University of Washington, and the
National Center for Toxicological Research
to examine the roles of DNA alkylation in
neurodegenerative disease and cancer.
Compounds being tested include methyl-
methoxymethanol, which comes from the
naturally occurring toxin cycasin (from a
plant in the cycad family), as well as N-
methyl-N-nitrosourea and methyl methane
sulfonate, both of which are synthetic com-
pounds found in grilled foods and smoke. 
The second project is a collaboration
with Duke University to identify a common
gene expression profile indicative of stress
response across organisms that include
yeast, the worm Caenorhabditis elegans, and
humans. The compounds tested thus far
include N-methyl-N´-nitro-nitrosoguani-
dine (an alkylating agent similar to methyl
methane sulfonate) and cadmium (a toxic
metal found in tap water). Test data are
being analyzed to identify signature profiles
for these toxicants, identify transcriptional
genes that are conserved, and define con-
served regulatory pathways that control the
response.
The third project is a collaboration with
the University of North Carolina at Chapel
Hill and the NIEHS to examine nuclear
receptor–mediated toxicity and oxidative
damage in mouse and human cells in the
liver bioreactor. Knockout mice that have
deletions in two different nuclear receptors
are being tested to see if responses to toxi-
cants are mediated by those receptors. 
Fundamental to these projects as well as
to the independent research projects of the
MIT CRM and other TRC members is the
quality of the gene expression data. An over-
arching goal of the TRC is cross-platform,
cross-laboratory comparison of gene expres-
sion profiling. Each participating member
has contributed results from a standard
experiment to a meta-analysis. MIT’s share
of the data was coordinated by Rebecca Fry,
a research scientist in computational and
systems biology and assistant director of the
MIT Microarray and Bioinformatics
Center. Fry analyzed the microarray data for
meaningful biological interpretation and
standardization. A meta-analysis of around
800 data sets from a consortiumwide
microarray study of two standardized bio-
logical samples revealed poor correlation
across laboratories and between platforms.
This provided the basis for recommenda-
tions for common steps in data processing
to improve data comparability between plat-
forms and investigators. Fry presented these
data at the 2004 TRC biannual conference.
The MIT Toxicogenomics Research
Program is making considerable contribu-
tion to the field of toxicogenomics.
Through the application of new computa-
tional tools to integrate high-quality data
sets including phenotypic responses to alky-
lation damage and known protein–protein
interactions, the Samson lab has illustrated
that interacting networks of proteins are
essential for recovery after damage. These
applications of systems biology have enabled
MIT to play a strong leadership role in
expanding the horizons in toxicogenomics.
With these broadened horizons we can
expect to ultimately see improved assess-
ment and predictive powers for environ-
mental health, new therapies and biomark-
ers for exposure, and environmental policies
that are based on more accurate scientific
knowledge. –Mary Eubanks
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ToxRAP Makes the
Connection
Environmental health professionals are
made, not born. That’s the ideology
behind the creation of ToxRAP™
(Toxicology, Risk Assessment, and
Pollution), an interactive curriculum for
grades kindergarten through 9. ToxRAP
was designed to help students understand
how elements of the environment around
them affect their health. The lessons were
developed by the Community Outreach
and Education Program (COEP) of the
NIEHS Center of Excellence located at the
Environmental and Occupational Health
Sciences Institute, jointly sponsored by
Rutgers and the University of Medicine
and Dentistry of New Jersey–Robert
Wood Johnson Medical School. 
The core of the curriculum design is
the ToxRAP Framework, which structures
each lesson in a way that enables students
to learn concepts central to the areas of
toxicology, environmental health, risk
assessment, and risk management. Under
the framework, students identify a health
problem, investigate the problem, reach a
conclusion about what’s causing the prob-
lem, then figure out how to control the
hazard. For example, in the lesson The
Case of the WTC Dust, middle school
students investigate
health risks faced by
fictitious New York
City residents in
ridding their build-
ing of toxic dust
after the 2001 col-
lapse of the World
Trade Center.
When integrat-
ing the ToxRAP cur-
riculum into their
lesson plans, teachers use three modules
that can be taught sequentially or inde-
pendently of each other. They use math,
health, science, and language arts activi-
ties that encourage the collection and
organization of real information to be
evaluated and analyzed using scientific
evidence. Teaching tools and techniques
include illustrated stories, games, graph-
ing, cooperative group exercises, hands-
on experiments, and case studies. 
Currently, ToxRAP reaches approxi-
mately 4,300 classrooms in 23 states, and
the developers have recently trained
teachers in Guam and Puerto Rico as
well. In addition to the English modules,
instructors in bilingual or English as a
Second Language classrooms can also
receive select portions of course content
in Spanish. 
According to Laura Hemminger,
codirector of the COEP, what makes the
program unique is that it
teaches younger students to
independently evaluate envi-
ronmental health problems,
which empowers them to take
some control of their own
environmental exposures.
Teachers admire the curricu-
lum’s ability to facilitate the
building of students’ critical
thinking skills by making the
learning experience challenging
and entertaining. 
“ToxRAP is an excellent
instructional model. It teaches
children every aspect of the sci-
entific method in an enjoyable,
interesting way. When I tell
students that it is time for sci-
ence, they applaud! They take
out their detective badges and
notebooks, and they are ready
to go to work,” says Laura
Steinberg, a fifth-
grade teacher in
Fords, New Jersey. 
The developers
of ToxRAP contin-
ue to expand the
program, and are
currently collabo-
rating with an
NIEHS small busi-
ness grantee to cre-
ate interactive activ-
ities to enhance
ToxRAP’s utility in
the classroom, and
to make it available
to students and
their families at
home. Also on the
horizon is a website, additional curricular
modules, and the use of student evaluations
on the program’s materials to shape future
curriculum content. –Tanya Tillett
Toxicogenomics
Data on
Acetaminophen
Now Available
The National Toxicology Program
(NTP), under the leadership of director
Kenneth Olden and deputy director
Christopher Portier, recently completed a
study of hepatic transcript levels follow-
ing exposure to the model hepatotoxicant
acetaminophen. The study was conducted
under the Principles of Good Laboratory
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Learning for life. The ToxRAP curriculum teaches young students about
the interconnections between enviromental exposures and human health. Practice, and the pathology diagnoses
were reviewed and approved following
standard NTP guidelines. 
The study involved 240 male F344/N
rats, half of which were dosed at night.
Exposure was a single oral gavage of doses
varying from nontoxic to toxic, with col-
lection of the left lobe of the liver for
transcript measurements at 6, 18, 24, and
48 hours after dosing. The RNA from
time-matched controls served as the refer-
ence sample, and 4 individual rats at each
dose and time were hybridized against the
controls using Agilent’s 60 mer rat oligo
microarray chip with 20,000 features.
With fluor reversals this resulted in 256
hybridizations. Hybridizations were done
under a National Center for Toxico-
genomics (NCT) contract. Details of the
study were published in volume 33, issue
1 (2005) of Toxicologic Pathology.
Toxicogenomics offers the promise of
the availability of large data sets that other
investigators can compare against their own
studies. Therefore, the NTP is making
available the microarray results, individual
animal pathology diagnoses, clinical chem-
istry, hepatic glutathione levels, and indi-
vidual animal data such as body weights.
These data are available at the NTP website
(http://ntp.niehs.nih.gov/a/apap.html).
The data will also be available in the NCT
Chemical Effects in Biological Systems
database, currently under development.
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Headliners Chromosomal Damage
NIEHS-Supported Research
Prenatal PAH Exposure Causes Genetic Changes in Newborns
Bocskay KA, Tang D, Orjuela MA, Liu X, Warburton DP, Perera FP. 2005. Chromosomal
aberrations in cord blood are associated with prenatal exposure to carcinogenic poly-
cyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev 14:506–511.
Research has suggested that in utero exposure to pollutants can cause DNA
damage, chromosomal changes, and increased risk of childhood cancers such
as leukemia. Other studies have indicated that pediatric leukemia is initiated
prior to birth. Now NIEHS grantee Frederica Perera and colleagues at
Columbia University demonstrate for the first time that prenatal exposure to
polycyclic aromatic hydrocarbons (PAHs) causes chromosomal changes that
have been linked to leukemia and other cancers.
PAHs are a group of more than 100 different chemicals that are formed
during the incomplete burning of almost any organic substance, including
coal, oil, and gasoline. PAHs can cross the placenta, and many have been
shown to cause cancer in animal studies.
The Columbia researchers used a technique known as fluorescence in situ
hybridization to identify and count the number and types of chromosomal
changes that occurred in a subset of 60 African-American and Dominican new-
borns from the Columbia Center for Children’s Environmental Health
Prospective Cohort Study in New York City. They measured chromosomal
changes in cultured white blood cells from umbilical cord blood. The
researchers assessed prenatal exposure via questionnaires administered to the
babies’ mothers during the third trimester of pregnancy, and by analyzing data
from personal air monitors that the mothers wore during their third trimester. 
The researchers found that exposure to airborne PAHs was significantly
associated with stable chromosomal aberrations. They also observed that
African-American babies had a higher frequency of chromosomal changes
than Dominican babies, suggesting the presence of either other unmeasured
factors or variations in susceptibility.
These findings suggest that prenatal exposures may cause the cytogenetic
damage that has been related to increased cancer risk, the researchers write.
This information has global importance because air pollution conditions simi-
lar to those in New York City exist in other cities in the United States and the
world. Although further research is necessary to confirm these findings and
to estimate the increase in cancer risk from the exposures, these results
demonstrate once again the importance of protecting children from avoid-
able harmful exposures. –Jerry Phelps
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Knowledge for all. A broad array of toxi-
cogenomics data on acetaminophen, a liver
toxicant, is now available to any researcher.